Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.32 -0.04 (11.11%)
Previous Close $0.36    52 Week High $ 
Open $0.35    52 Week Low $ 
Day High $0.35    P/E N/A 
Day Low $0.32    EPS $ 
Volume 184,559